Divi Resorts is reinforcing its commitment to making Caribbean travel more accessible, flexible, and rewarding for today's ...

Divi's Laboratories reported Q3FY26 results with a PAT of ₹583 crore, slightly down from ₹589 crore year-over-year. Total ...

The ever-popular scalp serum and root touch-up are now at a reduced price point, but it won’t last for long. The serum has earned rave reviews from me in particular, with the viral scalp serum also ...

Management said operational metrics improved during the quarter despite near-term revenue softness and indicated that growth ...

Feb 11 (Reuters) - Indian contract drug manufacturer Divi's Laboratories reported third-quarter profit below estimates on Wednesday, as high raw material costs and a one-off charge due to changes in ...

Murali Divi, the founder of Divi’s Labs, one of the top three manufacturers of active pharmaceutical ingredients (API) belongs to a small town in Andhra Pradesh. With his hard work, he established a ...

Divi's Labs reported a weaker-than-expected set of headline numbers on Wednesday.

Analysts have tweaked share price targets and future outlook after some of these companies announced their December quarter ...

The Hyderabad-based company's consolidated net profit marginally fell to ₹583 crore ($64.31 million) in the quarter ended December 31, from ₹589 crore a year earlier ...